2015 4th Quarter National Institutes of Health Awards:
|
Recipient
|
Amount
|
NIH Institute/Center
|
Albany Medical College: Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
|
$375,250
|
National Cancer Institute
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #01 - Performance Activity 1 Technical Support (1)
|
$22,213
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #01 - Performance Activity 1 Technical Support (2)
|
$22,213
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #02 - Petrukhin BPN-14967 (1)
|
$990,558
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #02 - Petrukhin BPN-14967 (2)
|
$990,558
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #03 - Gurney BPN-14770 (1)
|
$504,609
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #03 - Gurney BPN-14770 (2)
|
$504,609
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #04 - Wagner BPN-15606 (1)
|
$94,659
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: IGF Drug Manufacturing and Formulation Program (DMFP) Task Order #04 - Wagner BPN-15606 (2)
|
$94,659
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: Medicinal Chemistry for Neurotherapeutics Program (MCNP)
|
$762,929
|
National Institute of Neurological Disorders and Stroke
|
Albany Molecular Research: TAS Medicinal Chemistry for Neurotherapeutics Program (MCNP)
|
$762,929
|
National Institute of Neurological Disorders and Stroke
|
Athghin Biotechnology: Development of a High-Throughput Assay to Screen Chemical Compounds in Human Pluripotent Stem Cell Derived Neural Cells
|
$221,720
|
National Institute of Environmental Health Sciences
|
Athghin Biotechnology: Mass Spectrometric Screening of the Effect of Chemical Toxicants on the Human Epitranscriptome during Stem Cell Differentiation
|
$224,437
|
National Institute of Environmental Health Sciences
|
Regnerative Research Foundation: Quantifying Changes in Neural Stem Cell Lineages in the Aging Niche
|
$58,824
|
National Institute on Aging
|
SUNY Albany: Gamma Crystallin Modifications and Mechanisms of Lens Opacity
|
$346,500
|
National Eye Institute
|
SUNY Albany: Immigration Enforcement and the Health of Immigrants and their Children
|
$169,005
|
National Institute of Child Health and Human Development
|
Wadsworth Center: Environmental Phenols and Phthalates in Seminal Fluid - Implications for Male Fecundity
|
$299,366
|
National Institute of Child Health and Human Development
|
Wadsworth Center: IGF B Cell Epitope Discovery and Mechanisms of Antibody Protection
|
$1,553,857
|
National Institute of Allergy and Infectious Diseases
|
Wadsworth Center: IGF Environmental Phenols and Phthalates in Seminal Fluid - Implications for Male Fecundity
|
$299,366
|
National Institute of Child Health and Human Development
|
Virtual Phantoms, Inc.: ARCHER - An Extremely Fast Medical Radiation Dose Computing Software
|
$165,220
|
National Institute of Biomedical Imaging and Bioengineering
|
TOTAL
|
$8,463,481
|
|